We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
60 result(s) found, displaying 21 to 30
-
Prescription medicine decision summaryRelfydess (relabotulinumtoxinA, purified Botulinum toxin type A) has been approved for the temporary improvement in the appearance of glabellar lines ("frown lines") and lateral canthal lines ("crows feet").
-
Cancellation by sponsorRequested by Ipsen Pty Ltd
-
Cancellation by sponsorRequested by Ipsen Pty Ltd
-
Prescription medicine decision summarySohonos (palovarotene) is approved to reduce the formation of heterotopic ossification.
-
-
FORLAX macrogol 4000 10g powder for oral solution sachet Cancelled under Section 30(1)(c) of the Act
Cancellation by sponsorRequested by Ipsen Pty Ltd -
-
Prescription medicine registrationActive ingredients: cabozantinib (S)-malate.
-
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for INCRELEX mecasermin 10 mg/mL solution for injection vial.